WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced it has entered into an ...
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Co announces that clinical findings for three different TAP compounds for the treatment of solid tumors are to be reported at the 43rd American Society of Clinical Oncology Annual Meeting to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results